UnitedHealth Common Stock vs Deferred Long Term Liab Analysis

UNH Stock

USD 511.15 5.05 1.00%

UnitedHealth Group financial indicator trend analysis is much more than just breaking down UnitedHealth Group prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether UnitedHealth Group is a good investment. Please check the relationship between UnitedHealth Group Common Stock and its Deferred Long Term Liab accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Common Stock vs Deferred Long Term Liab

Common Stock vs Deferred Long Term Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of UnitedHealth Group Common Stock account and Deferred Long Term Liab. At this time, the significance of the direction appears to have strong relationship.

The correlation between UnitedHealth Group's Common Stock and Deferred Long Term Liab is 0.79. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Deferred Long Term Liab in the same time period over historical financial statements of UnitedHealth Group Incorporated, assuming nothing else is changed. The correlation between historical values of UnitedHealth Group's Common Stock and Deferred Long Term Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of UnitedHealth Group Incorporated are associated (or correlated) with its Deferred Long Term Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Deferred Long Term Liab has no effect on the direction of Common Stock i.e., UnitedHealth Group's Common Stock and Deferred Long Term Liab go up and down completely randomly.

Correlation Coefficient

0.79

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Common Stock

Deferred Long Term Liab

Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.

Most indicators from UnitedHealth Group's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into UnitedHealth Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

As of now, UnitedHealth Group's Selling General Administrative is increasing as compared to previous years. The UnitedHealth Group's current Enterprise Value is estimated to increase to about 500.3 B, while Tax Provision is projected to decrease to under 5 B.

	2021	2022	2023	2024 (projected)
Total Revenue	285.3B	322.1B	367.5B	385.9B
Depreciation And Amortization	3.1B	3.4B	4.0B	4.2B

Total Revenue Depreciation And Amortization

UnitedHealth Group fundamental ratios Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Long Term Debt Total	Intangible Assets	Other Current Liab	Short Term Debt	Accounts Payable	Short Term Investments	Common Stock	Good Will	Common Stock Total Equity
Total Assets		1.0	0.99	0.98	0.95	1.0	0.97	1.0	0.65	0.97	0.96	0.47	1.0	0.12	0.86	1.0	1.0	0.99	0.97	0.87	0.35	0.84	0.84	0.39	1.0	0.4
Total Current Liabilities	1.0		0.99	0.98	0.95	0.99	0.97	1.0	0.65	0.97	0.96	0.46	1.0	0.13	0.86	1.0	1.0	0.99	0.98	0.86	0.39	0.84	0.83	0.39	1.0	0.4
Total Stockholder Equity	0.99	0.99		0.98	0.93	1.0	0.96	0.99	0.67	0.97	0.94	0.52	0.99	0.16	0.86	0.99	0.99	0.97	0.96	0.86	0.3	0.83	0.85	0.43	0.99	0.44
Property Plant And Equipment Net	0.98	0.98	0.98		0.97	0.98	0.91	0.99	0.63	0.92	0.9	0.49	0.98	0.18	0.82	0.98	0.96	0.98	0.97	0.87	0.36	0.8	0.86	0.43	0.98	0.44
Net Debt	0.95	0.95	0.93	0.97		0.93	0.86	0.96	0.58	0.87	0.87	0.4	0.96	0.16	0.77	0.96	0.93	0.98	0.99	0.86	0.5	0.75	0.81	0.35	0.96	0.36
Retained Earnings	1.0	0.99	1.0	0.98	0.93		0.97	1.0	0.66	0.97	0.96	0.49	0.99	0.13	0.86	0.99	0.99	0.98	0.96	0.86	0.31	0.84	0.84	0.41	0.99	0.42
Cash	0.97	0.97	0.96	0.91	0.86	0.97		0.96	0.6	1.0	0.97	0.48	0.96	0.08	0.88	0.96	0.98	0.95	0.92	0.81	0.31	0.85	0.8	0.39	0.96	0.4
Non Current Assets Total	1.0	1.0	0.99	0.99	0.96	1.0	0.96		0.66	0.97	0.95	0.47	1.0	0.13	0.85	1.0	0.99	0.99	0.98	0.87	0.35	0.84	0.85	0.39	1.0	0.4
Non Currrent Assets Other	0.65	0.65	0.67	0.63	0.58	0.66	0.6	0.66		0.57	0.67	0.16	0.64	0.03	0.53	0.65	0.64	0.61	0.56	0.47	0.25	0.64	0.3	0.13	0.62	0.14
Cash And Short Term Investments	0.97	0.97	0.97	0.92	0.87	0.97	1.0	0.97	0.57		0.95	0.52	0.97	0.12	0.88	0.97	0.99	0.95	0.93	0.83	0.31	0.84	0.85	0.42	0.97	0.43
Net Receivables	0.96	0.96	0.94	0.9	0.87	0.96	0.97	0.95	0.67	0.95		0.3	0.96	-0.09	0.91	0.96	0.97	0.93	0.91	0.82	0.24	0.83	0.71	0.2	0.95	0.21
Common Stock Shares Outstanding	0.47	0.46	0.52	0.49	0.4	0.49	0.48	0.47	0.16	0.52	0.3		0.44	0.57	0.21	0.45	0.46	0.45	0.45	0.46	0.29	0.3	0.66	0.88	0.47	0.89
Non Current Liabilities Total	1.0	1.0	0.99	0.98	0.96	0.99	0.96	1.0	0.64	0.97	0.96	0.44		0.1	0.86	1.0	0.99	0.99	0.98	0.88	0.35	0.82	0.83	0.35	1.0	0.36
Other Current Assets	0.12	0.13	0.16	0.18	0.16	0.13	0.08	0.13	0.03	0.12	-0.09	0.57	0.1		-0.08	0.12	0.09	0.14	0.16	0.12	0.29	0.06	0.36	0.65	0.12	0.65
Other Stockholder Equity	0.86	0.86	0.86	0.82	0.77	0.86	0.88	0.85	0.53	0.88	0.91	0.21	0.86	-0.08		0.86	0.88	0.84	0.83	0.71	0.11	0.78	0.72	0.12	0.86	0.13
Total Liab	1.0	1.0	0.99	0.98	0.96	0.99	0.96	1.0	0.65	0.97	0.96	0.45	1.0	0.12	0.86		0.99	0.99	0.98	0.86	0.38	0.84	0.83	0.38	1.0	0.39
Total Current Assets	1.0	1.0	0.99	0.96	0.93	0.99	0.98	0.99	0.64	0.99	0.97	0.46	0.99	0.09	0.88	0.99		0.98	0.96	0.86	0.34	0.84	0.82	0.37	0.99	0.38
Short Long Term Debt Total	0.99	0.99	0.97	0.98	0.98	0.98	0.95	0.99	0.61	0.95	0.93	0.45	0.99	0.14	0.84	0.99	0.98		0.99	0.87	0.44	0.81	0.83	0.38	0.99	0.39
Intangible Assets	0.97	0.98	0.96	0.97	0.99	0.96	0.92	0.98	0.56	0.93	0.91	0.45	0.98	0.16	0.83	0.98	0.96	0.99		0.87	0.48	0.79	0.86	0.37	0.98	0.39
Other Current Liab	0.87	0.86	0.86	0.87	0.86	0.86	0.81	0.87	0.47	0.83	0.82	0.46	0.88	0.12	0.71	0.86	0.86	0.87	0.87		0.27	0.46	0.78	0.31	0.88	0.32
Short Term Debt	0.35	0.39	0.3	0.36	0.5	0.31	0.31	0.35	0.25	0.31	0.24	0.29	0.35	0.29	0.11	0.38	0.34	0.44	0.48	0.27		0.3	0.27	0.46	0.36	0.46
Accounts Payable	0.84	0.84	0.83	0.8	0.75	0.84	0.85	0.84	0.64	0.84	0.83	0.3	0.82	0.06	0.78	0.84	0.84	0.81	0.79	0.46	0.3		0.63	0.31	0.82	0.31
Short Term Investments	0.84	0.83	0.85	0.86	0.81	0.84	0.8	0.85	0.3	0.85	0.71	0.66	0.83	0.36	0.72	0.83	0.82	0.83	0.86	0.78	0.27	0.63		0.55	0.85	0.56
Common Stock	0.39	0.39	0.43	0.43	0.35	0.41	0.39	0.39	0.13	0.42	0.2	0.88	0.35	0.65	0.12	0.38	0.37	0.38	0.37	0.31	0.46	0.31	0.55		0.38	1.0
Good Will	1.0	1.0	0.99	0.98	0.96	0.99	0.96	1.0	0.62	0.97	0.95	0.47	1.0	0.12	0.86	1.0	0.99	0.99	0.98	0.88	0.36	0.82	0.85	0.38		0.39
Common Stock Total Equity	0.4	0.4	0.44	0.44	0.36	0.42	0.4	0.4	0.14	0.43	0.21	0.89	0.36	0.65	0.13	0.39	0.38	0.39	0.39	0.32	0.46	0.31	0.56	1.0	0.39

Click cells to compare fundamentals

UnitedHealth Group Account Relationship Matchups

UnitedHealth Group fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	173.9B	197.3B	212.2B	245.7B	273.7B	287.4B
Total Current Liabilities	61.8B	72.4B	78.3B	89.2B	99.1B	104.0B
Total Stockholder Equity	60.4B	65.5B	71.8B	77.8B	88.8B	93.2B
Property Plant And Equipment Net	8.7B	8.6B	9.0B	10.1B	11.5B	12.0B
Net Debt	29.7B	26.5B	24.6B	34.3B	37.1B	39.0B
Retained Earnings	61.2B	69.3B	77.1B	86.2B	95.8B	100.6B
Cash	11.0B	16.9B	21.4B	23.4B	25.4B	26.7B
Non Current Assets Total	131.3B	143.6B	150.4B	176.6B	195.3B	205.0B
Non Currrent Assets Other	94.0B	102.3B	107.3B	12.3B	64.9B	68.2B
Cash And Short Term Investments	14.2B	19.8B	23.9B	27.9B	29.6B	31.1B
Net Receivables	11.8B	25.4B	28.1B	30.5B	39.0B	40.9B
Common Stock Shares Outstanding	966M	961M	956M	950M	938M	1.2B
Liabilities And Stockholders Equity	173.9B	197.3B	212.2B	245.7B	273.7B	287.4B
Non Current Liabilities Total	49.9B	54.3B	57.4B	70.1B	80.4B	84.5B
Other Current Assets	16.6B	8.5B	9.8B	10.7B	9.8B	6.2B
Other Stockholder Equity	16M	2.8B	3.3B	3.7B	4.2B	4.4B
Total Liab	111.7B	126.8B	135.7B	159.4B	174.8B	183.5B
Total Current Assets	42.6B	53.7B	61.8B	69.1B	78.4B	82.4B
Short Long Term Debt Total	40.7B	43.5B	46.0B	57.6B	62.5B	65.7B
Intangible Assets	10.3B	10.9B	10.0B	14.4B	15.2B	16.0B
Other Current Liab	33.6B	20.4B	23.0B	26.3B	59.5B	62.4B
Short Term Debt	3.9B	4.8B	3.6B	3.1B	4.3B	2.5B
Accounts Payable	21.7B	44.4B	49.1B	56.8B	32.0B	33.6B
Short Term Investments	3.3B	2.9B	2.5B	4.5B	4.2B	4.4B
Accumulated Other Comprehensive Income	(3.6B)	(3.8B)	(5.4B)	(8.4B)	(7.0B)	(6.7B)
Good Will	65.7B	71.3B	75.8B	93.4B	103.7B	108.9B
Property Plant And Equipment Gross	8.7B	8.6B	15.0B	17.1B	18.5B	19.4B
Other Liab	10.0B	15.7B	15.1B	11.8B	13.5B	14.2B
Other Assets	13.8B	52.8B	107.3B	20.7B	(4.7B)	(4.5B)
Long Term Debt	36.8B	38.6B	42.4B	54.5B	58.3B	61.2B
Property Plant Equipment	8.7B	8.6B	9.0B	10.1B	11.6B	12.2B
Current Deferred Revenue	2.6B	2.8B	2.6B	3.1B	3.4B	2.5B
Net Tangible Assets	(16.7B)	(14.5B)	75.0B	(25.1B)	(28.8B)	(27.4B)
Noncontrolling Interest In Consolidated Entity	2.8B	2.8B	3.3B	3.7B	4.2B	4.4B
Retained Earnings Total Equity	61.2B	69.3B	77.1B	86.2B	99.1B	51.1B
Long Term Debt Total	36.8B	38.6B	42.4B	54.5B	62.7B	65.8B

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:

How To Invest In UnitedHealth

Details

Is UnitedHealth Stock a good investment?

Details

What is UnitedHealth Group's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UnitedHealth Group Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.043

Dividend Share

7.96

Earnings Share

15.39

Revenue Per Share

427.221

Quarterly Revenue Growth

0.092

The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

UnitedHealth Common Stock vs Deferred Long Term Liab Analysis

Common Stock vs Deferred Long Term Liab

Common Stock vs Deferred Long Term Liab Correlation Analysis

Correlation Coefficient

Common Stock

Deferred Long Term Liab

UnitedHealth Group fundamental ratios Correlations

UnitedHealth Group Account Relationship Matchups

High Positive Relationship

High Negative Relationship

UnitedHealth Group fundamental ratios Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 1.0	Total Assets
Retained Earnings	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Non Current Liabilities Total	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets

Other Current Assets	- 0.09	Net Receivables
Other Stockholder Equity	- 0.08	Other Current Assets